Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma

Table 1 Diagnostic value of plasma miR-21 and miR-93 for clinicopathological features of esophageal squamous cell carcinoma patients

Pathological feature	AUC	95%CI	SE	Cut-off	Sensitivity (%)	Specificity (%)
MiR-21
T stage	0.819	0.740-0.899	0.041	6.52	80.00	71.43
N stage	0.758	0.666-0.851	0.047	5.90	67.02	79.41
M stage	0.824	0.740-0.908	0.043	6.34	85.71	70.00
Pathological differentiation	0.725	0.637-0.812	0.044	6.20	80.85	59.26
MiR-93
T stage	0.827	0.742-0.911	0.043	4.37	73.33	80.61
N stage	0.815	0.733-0.896	0.041	3.34	74.47	76.47
M stage	0.814	0.722-0.906	0.047	5.36	57.14	97.00

AUC: Area under the receiver operating characteristic curve; CI: Confidence interval.